US2008243140A1PendingUtilityA1
Spacing devices for releasing active substances in the paranasal sinus
Est. expiryFeb 6, 2021(expired)· nominal 20-yr term from priority
A61L 31/10A61L 2300/414A61L 2300/602A61L 2300/43A61K 9/0092A61K 9/0043A61L 2300/258A61L 2300/222A61L 31/16A61L 2300/434A61L 2300/432A61F 2/186
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to a spacing device (stent) for use in fenestrations of the paranasal sinus. Said device consists of a sheath which forms a hollow body, surrounding an internal cavity. An active substance, which is released in a controlled manner by the spacing device, is contained in the sheath or in at least one layer of the sheath. The relationship q of the external diameter of the hollow body to the internal diameter of the hollow body is expressed by 1.2≦q≦3.0.
Claims
exact text as granted — not AI-modified1 . A method for treating a disorder that affects a paranasal sinus, middle ear or trachea, said method comprising the steps of:
A) providing a substance delivering device that is implantable in an opening of a paranasal sinus, middle ear or trachea, said device comprising a tubular body having a wall, a lumen, first and second open ends, an outer surface, an inner surface and a substance containing layer, the substance containing layer comprising a matrix that contains therapeutic substance such that a therapeutically effective amount of the substance will elute from the device while implanted, wherein said therapeutic substance comprises at least one steroid; and B) implanting the device in an opening of a paranasal sinus, middle ear or trachea such that a therapeutic amount of the therapeutic substance is delivered to the paranasal sinus, middle ear or trachea in which the device is implanted.
2 . A method according to claim 1 wherein Step B comprises implanting the device in an opening of a paranasal sinus.
3 . A method according to claim 1 wherein Step B comprises implanting the device in an opening of a frontal sinus.
4 . A method according to claim 1 wherein Step B comprises implanting the device in an opening of a paranasal sinus that has been dilated.
5 . A method according to claim 1 wherein Step B comprises implanting the device in an opening of a paranasal sinus that has been surgically altered.
6 . A method according to claim 5 wherein the device is implanted in a surgically created fenestration.
7 . A method according to claim 1 wherein the device is capable of being radially expanded and wherein Step B comprises radially expanding the device at an intended site of implantation.
8 . A method according to claim 7 wherein the device is radially expanded by inflating a balloon positioned within the device.
9 . A method according to claim 1 further comprising the step of:
C) removing the device.
10 . A method according to claim 9 wherein the device is removed approximately 2 to 12 weeks after implantation.Join the waitlist — get patent alerts
Track US2008243140A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.